Skip to Content

Matthew Weinstock

Matthew Weinstock is a Group Leader at the biotechnology company AbSci where he is currently leading a team of scientists in the Molecular Sciences group in developing bacterial strains to produce complex biopharmaceuticals.  Previously he was a scientist at Synthetic Genomics, Inc. where he focused on large-scale genome engineering of novel microorganisms for biotech applications. He earned his Ph.D. in biochemistry from the University of Utah, where he worked on the discovery and development of mirror-image peptide therapeutics for emerging infectious diseases.